Other battles

Online privacy, clean air, affordable housing, whistleblower protection and much more: which other corporate lobby fights are putting EU public interest on the line?

The crusade against 'red tape': How the European Commission and big business push for deregulation

31.10.2014

A crusade for big business-friendly deregulation, waged during José Manuel Barroso's Presidency of the European Commission, shows no signs of stopping. This neoliberal push to weaken or block new legislation appears likely to expand with Jean-Claude Juncker's new Commission team.

Health

The EU Chief Scientific Adviser and endocrine disrupting chemicals

29.10.2014

Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.

Health

Will Barroso provide answers about tobacco industry contacts before leaving the Berlaymont?

16.10.2014

As part of her inquiry into the Commission's implementation of UN tobacco lobby rules, European Ombudsman Emily O'Reilly has asked Commission President Barroso for “a supplementary opinion” with proper answers to questions raised in her inquiry. O'Reilly took this step after having received a seriously unconvincing letter from Barroso that fails to address the specific questions and arguments put forward by CEO in the complaint that sparked the Ombudsman's inquiry.

Health

Chemical conflicts: Inadequate independence policies for EU's expert risk assessors

25.09.2014

New research on the safety assessment of four controversial chemicals shows that two thirds (67%) of the scientists involved had at least one, and some many more, conflicts of interest due to their links to industries impacted by the assessments.

Health

Endocrination: new film exposing lobby battle on endocrine disrupting chemicals

12.09.2014

This must-watch film is now online. The film shows how corporations and actors within the Commission are teaming up to demolish a major piece of public health legislation.

EU institutions

Chief Scientific Adviser: remarks on a problematic position, and a suggestion to Sense about Science

08.08.2014

A few observations on the debate sparked by our open letter on the position of Chief Scientific Advisor to the President of the European Commission, and on the need for proper scientific advice to EU legislators.

EU institutions

The position of Chief Scientific Advisor to the President of the European Commission

22.07.2014

The position of Chief Scientific Adviser to the President of the European Commission is problematic, concentrating too much influence in one person and undermining other Commission research and assessment processes. We ask Mr Juncker, the new President of the European Commission, to scrap the position.

Health

Supervisory Committee releases 29-page critical assessment of OLAF's Dalligate investigation

06.07.2014

OLAF's supervisory committee has sent CEO its 29-page report, so far treated as confidential, on the anti-fraud agency's handling of the investigation that led to the forced resignation of EU health commissioner John Dalli (Opinion 2/2012).

Health

Ombudsman investigates EU Commission's failure to implement UN tobacco lobby rules

02.07.2014

The European Ombudsman, Emily O'Reilly, has now confirmed that she will investigate the European Commission's failure to properly implement UN rules for contacts with tobacco lobbyists, following a complaint submitted by Corporate Europe Observatory (CEO).

Health

Mediapart exposes unhealthy liaisons between French MEP and the tobacco industry

30.06.2014

Fresh evidence from the French online newspaper Mediapart has cast new light on just how intimate the relations between the controversial tobacco industry and MEPs can be.

Big banks

What are bankers doing inside EU summits?

23.01.2012

Crucial decisions “to save the Euro” and “to save Greece” were made at the Euro Summits in July and October 2011. While the decision making process was taking place, the press reported several informal negotiations between EU leaders and the banks, mostly represented by the Institute of International Finance (IIF). What was exactly the role of this lobby group in the final decisions? And what did it get from the deal?

Militarisation

Lobbying warfare

21.09.2011

Lobbying Warfare - the arms industry's role in building a military Europe maps out the key players in the defence and security lobby in Brussels, and highlights how the industry's close alliance with EU decision makers has contributed to the expansion of the EU's defence and security structures, and to the overall militarisation of EU foreign policy.

Other battles

The crusade against 'red tape': How the European Commission and big business push for deregulation

The EU Chief Scientific Adviser and endocrine disrupting chemicals

Will Barroso provide answers about tobacco industry contacts before leaving the Berlaymont?

Chemical conflicts: Inadequate independence policies for EU's expert risk assessors

Endocrination: new film exposing lobby battle on endocrine disrupting chemicals

Chief Scientific Adviser: remarks on a problematic position, and a suggestion to Sense about Science

The position of Chief Scientific Advisor to the President of the European Commission

Supervisory Committee releases 29-page critical assessment of OLAF's Dalligate investigation

Ombudsman investigates EU Commission's failure to implement UN tobacco lobby rules

Mediapart exposes unhealthy liaisons between French MEP and the tobacco industry

What are bankers doing inside EU summits?

Lobbying warfare

Help us stay independent